Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5702381 | Surgical Oncology | 2017 | 17 Pages |
Abstract
The evidence base for curatively intended treatments of esophageal and gastroesophageal junction cancer is not very strong. Several on-going trials have the potential to change the gold standard treatments of today.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Fredrik Klevebro, Simon Ekman, Magnus Nilsson,